Eradication rate of Helicobacter pylori in dyspeptic patients

Medical Science Monitor

Volumn 11, Issue 4, 2005, Pages

  Amini, Mohsen ^a   Khedmat, Hossein ^a,c   Yari, Fatemeh ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Physicians Bldg ^*  (Iran)

Author keywords

Eradication; Helicobacter pylori; Treatment

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CIPROFLOXACIN; FURAZOLIDONE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UREA BREATH TEST;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BREATH TESTS; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FURAZOLIDONE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; SINGLE-BLIND METHOD; TETRACYCLINE; TREATMENT OUTCOME; UREA;

EID: 17444425335     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Howden CW, Hunt RH: Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroeterology. Am J Gastroenterol, 1998; 93: 2330-38
2. Debates-Ossenkopp YJ, Herscheid AJ, Pot RG et al; Prevalence of Helicobecter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimiciob Chemother Apr, 1999; 43(4): 511-15
3. Choi IJ, Jung HC, Choi KW et al: Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. Aliment pharmacol Ther Jan, 2002; 16(1): 145-51
4. Graham DY, Hoffman J, Anderson SY et al: Ranitidin bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Aliment pharmacol Ther Feb, 1999; 13(2): 169-72
5. Zullo A, Rinaldi V, Pugliano F et al: Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. Am J Gastroenterol, 1997; 92(11): 2029-31
6. Williams Mp, Hamilton MR, Sercombe JC et al: Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Aliment Pharmacol Ther, 1997; 11(4): 705-10
7. Park KN, Hahm JS, Kim HJ: Pharmacological effects of metronidazole + tetracycline + bismuth subcitrate versus omeprazole + amoxycillin + bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Eur J Gastroenterol Hepatol, 1994; 6)Supp.1):S103-7
8. Al-Assi MT, Ramirez FC, Lew GM et al: Clarithromycin, tetracycline and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroentrol, 1994; 89(8): 1203-5
9. Amini M, Malekzadeh R, Massarat S et al: Comparative study of effectiveness of conventional outpatient antihelicobacter therapy, using labeled urea breath test. Kowsar Med J, 1980; 6(2): 111-20
10. Malekzadeh R, Ansari R, Vahidi H et al: Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal disease. Aliment pharmacol Ther Mar, 2000; 14(3): 299-303
11. Mansour-Ghanaei F, Fallah MS, Shafaghi A: Eradication of Helicobacter pylori in duodenal ulcer disease with tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy. Med Sci Monit, 2002; 8(3): 27-30
12. Novis BH, Gabay G, Naftali T et al: Helicobacter pylori the middle east scenario. Yale J Biol Med, 1998; 71 (2): 135-41
13. Dresner D, Coyle W, Nemee R et al: Efficacy of ciprofloxacin in the eradication of Helicobacter pylori. South Med J Aug, 1996; 89(8): 775-78
14. Labenz J, Gyenes E, Peitz U et al: Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori. Z Gasteroenterol Apr, 1991; 29(4): 143-45
15. Ebrahimi-Daryani N, Mirmomen S, Mansour-Ghanaei F et al: The efficacy of furazolidone-based quadruple therapy eradication of Helicobacter pylori in Iranian patients resistant to meteoroidazole-based quadruple therapy. Med Sci Monit, 2003; 9(8): 105-8
16. Kyzekove J, Arlt J, Arltova M: Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology, 2001; 48(38): 594-602
17. Bobrzynski A, Beben P, Budzynski A et al: Incidence of complications of peptic ulcers in patients with Helicobacter pylori (HP) infection and/or NSAID use in the era of HP eradication. Med Sci Monit, 2002; 8(8): CR554-57
18. Miguel Baena Diez J, Lopez Mompo C, Rams Rams F et al: Efficacy of a multistep strategy for Helicobacter pylori eradication; quadruple therapy with omeprazole, tetracycline and bismuth after failure of combination of omeprazole, clarithromycin and amoxycillin. Med Clin (Barc), 2000; 115(16): 617-19
19. Xiao SD, Liu WZ, Hu PJ et al: A multicenter study on eradication of Helicobacter pylori using four 1-week triple therapies in china. Aliment Pharmacol Ther, 2001; 15(1): 81-86